BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31858335)

  • 1. Analysis of anti-RNA polymerase III antibodies in Chinese Han systemic sclerosis patients.
    Liu C; Hou Y; Xu D; Li L; Zhang Y; Cheng L; Yan S; Zhang F; Li Y
    Clin Rheumatol; 2020 Apr; 39(4):1191-1197. PubMed ID: 31858335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme-linked immunosorbent assay for detection of anti-RNA polymerase III antibody: analytical accuracy and clinical associations in systemic sclerosis.
    Kuwana M; Okano Y; Pandey JP; Silver RM; Fertig N; Medsger TA
    Arthritis Rheum; 2005 Aug; 52(8):2425-32. PubMed ID: 16052583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay.
    Satoh T; Ishikawa O; Ihn H; Endo H; Kawaguchi Y; Sasaki T; Goto D; Takahashi K; Takahashi H; Misaki Y; Mimori T; Muro Y; Yazawa N; Sato S; Takehara K; Kuwana M
    Rheumatology (Oxford); 2009 Dec; 48(12):1570-4. PubMed ID: 19808694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA.
    Santiago M; Baron M; Hudson M; Burlingame RW; Fritzler MJ
    J Rheumatol; 2007 Jul; 34(7):1528-34. PubMed ID: 17610318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low prevalence of anti-RNA polymerase III antibodies in a French scleroderma population: anti-RNA polymerase III scleroderma.
    Faucher B; Stein P; Granel B; Weiller PJ; Disdier P; Serratrice J; Harlé JR; Durand JM; Frances Y; Guis S; Pham T; Bardin N; Sanmarco M
    Eur J Intern Med; 2010 Apr; 21(2):114-7. PubMed ID: 20206882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.
    Nikpour M; Hissaria P; Byron J; Sahhar J; Micallef M; Paspaliaris W; Roddy J; Nash P; Sturgess A; Proudman S; Stevens W
    Arthritis Res Ther; 2011; 13(6):R211. PubMed ID: 22189167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining.
    Ceribelli A; Krzyszczak ME; Li Y; Ross SJ; Chan JY; Chan EK; Burlingame RW; Webb TT; Bubb MR; Sobel ES; Reeves WH; Satoh M
    Arthritis Res Ther; 2011 Jul; 13(4):R119. PubMed ID: 21781293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of autoantibodies against RNA polymerases using immunoaffinity-purifed RNA polymerase I, II, and III antigen in an enzyme-linked immunosorbent assay.
    Chang M; Wang RJ; Yangco DT; Sharp GC; Komatireddy GR; Hoffman RW
    Clin Immunol Immunopathol; 1998 Oct; 89(1):71-8. PubMed ID: 9756726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an immunodominant epitope on RNA polymerase III recognized by systemic sclerosis sera: application to enzyme-linked immunosorbent assay.
    Kuwana M; Kimura K; Kawakami Y
    Arthritis Rheum; 2002 Oct; 46(10):2742-7. PubMed ID: 12384934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexistence of anti-RNA polymerase III and anti-U1RNP antibodies in patients with systemic lupus erythematosus: two cases without features of scleroderma.
    Satoh M; Vazquez-Del Mercado M; Krzyszczak ME; Li Y; Ceribelli A; Burlingame RW; Webb TT; Sobel ES; Reeves WH; Chan EK
    Lupus; 2012 Jan; 21(1):68-74. PubMed ID: 22025191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
    Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
    J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of anti-RNA polymerase III antibodies in systemic sclerosis: New data from a French cohort and a systematic review and meta-analysis.
    Sobanski V; Dauchet L; Lefèvre G; Lambert M; Morell-Dubois S; Sy T; Hachulla E; Hatron PY; Launay D; Dubucquoi S
    Arthritis Rheumatol; 2014 Feb; 66(2):407-17. PubMed ID: 24504813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies.
    Hamaguchi Y; Kodera M; Matsushita T; Hasegawa M; Inaba Y; Usuda T; Kuwana M; Takehara K; Fujimoto M
    Arthritis Rheumatol; 2015 Apr; 67(4):1045-52. PubMed ID: 25512203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and serological associations with anti-RNA polymerase antibodies in systemic sclerosis.
    Harvey GR; Butts S; Rands AL; Patel Y; McHugh NJ
    Clin Exp Immunol; 1999 Aug; 117(2):395-402. PubMed ID: 10444276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serologic profile and mortality rates of scleroderma renal crisis in Italy.
    Codullo V; Cavazzana I; Bonino C; Alpini C; Cavagna L; Cozzi F; Del Papa N; Franceschini F; Guiducci S; Morozzi G; Ruffatti A; Ferri C; Giacomelli R; Matucci-Cerinic M; Valentini G; Montecucco C
    J Rheumatol; 2009 Jul; 36(7):1464-9. PubMed ID: 19487262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of anti-IFI16 antibodies by ELISA: clinical and serological associations in systemic sclerosis.
    Costa S; Mondini M; Caneparo V; Afeltra A; Airò P; Bellisai F; Faggioli P; Gerli R; Lotzniker M; Meroni PL; Morozzi G; Radice A; Riccieri V; Scarsi M; Sebastiani GD; Sinico RA; Tincani A; Gariglio M; Landolfo S
    Rheumatology (Oxford); 2011 Apr; 50(4):674-81. PubMed ID: 21134960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies.
    Airo' P; Ceribelli A; Cavazzana I; Taraborelli M; Zingarelli S; Franceschini F
    J Rheumatol; 2011 Jul; 38(7):1329-34. PubMed ID: 21459934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class II alleles in systemic sclerosis patients with anti-RNA polymerase I/III antibody: associations with subunit reactivities.
    Kuwana M; Pandey JP; Silver RM; Kawakami Y; Kaburaki J
    J Rheumatol; 2003 Nov; 30(11):2392-7. PubMed ID: 14677183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma.
    Maes L; Blockmans D; Verschueren P; Westhovens R; De Beéck KO; Vermeersch P; Van den Bergh K; Burlingame RW; Mahler M; Bossuyt X
    Clin Chim Acta; 2010 Jul; 411(13-14):965-71. PubMed ID: 20346932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of the relationship between autoantibodies and clinical findings in patients with systemic sclerosis.
    Yayla ME; İlgen U; Düzgün N
    Turk J Med Sci; 2018 Feb; 48(1):10-15. PubMed ID: 29479936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.